Actions of dopaminergic agonists on cyclic AMP production in rat brain homogenates.
D000818:Animals; D000978:Antiparkinson Agents; D001058:Apomorphine / Q000031:analogs & derivatives / Q000494:pharmacology; D001060:Aporphines / Q000494:pharmacology; D003994:Bucladesine / Q000494:pharmacology; D003342:Corpus Striatum / Q000378:metabolism*; D000242:Cyclic AMP / Q000096:biosynthesis*; D004298:Dopamine / Q000031:analogs & derivatives / Q000378:metabolism* / Q000494:pharmacology; D007546:Isoquinolines / Q000031:analogs & derivatives / Q000494:pharmacology; D008297:Male; D009281:Naphthalenes / Q000494:pharmacology; D010300:Parkinson Disease / Q000188:drug therapy; D010891:Piribedil / Q000031:analogs & derivatives / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug; D014149:Tranquilizing Agents / Q000494:pharmacology
D000978:Antiparkinson Agents; D001060:Aporphines; D007546:Isoquinolines; D009281:Naphthalenes; D011955:Receptors, Drug; D014149:Tranquilizing Agents; D003994:Bucladesine; D010891:Piribedil; D000242:Cyclic AMP; D001058:Apomorphine; D004298:Dopamine